SCHEMBL5483041

SCHEMBL5483041

NS(=O)(=O)NCCCCCC(=O)Nc1cc(OCc2cccnc2)cc2cccnc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 13/20 0.73
HDAC1 Q13547 6/20 0.52
HDAC8 Q9BY41 5/20 0.46
HDAC3 O15379 4/20 0.44
HDAC4 P56524 4/20 0.44
HDAC7 Q8WUI4 4/20 0.44
HDAC2 Q92769 4/20 0.44
HDAC10 Q969S8 4/20 0.44
HDAC11 Q96DB2 4/20 0.44
HDAC9 Q9UKV0 4/20 0.44
HDAC5 Q9UQL6 4/20 0.44
HTT P42858 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
TP53 P04637 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC40A1 Q9NP59 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5325195 0.92 HDAC6 (0.77) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5490501 0.91 HDAC6 (0.76) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5480677 0.86 HDAC6 (0.76) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5457540 0.85 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5327799 0.82 HDAC6 (0.77) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL8404193 0.80 KMT2A (0.47) HDAC6HDAC1HDAC8HTTALDH1A1
SCHEMBL8103401 0.79 HDAC6 (0.57) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5330834 0.79 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC3HDAC4
Hydrochloric Acid SCHEMBL5323573 0.78 HDAC6 (0.56) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL5326813 0.76 HDAC6 (0.69) HDAC6HDAC1HDAC8HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC6 11/4885HDAC1 1/4885HDAC8 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.